‘Fast-fail’ AI blood test could steer patients with pancreatic cancer away from ineffective therapies
An artificial intelligence technique for detecting DNA fragments shed by tumours and circulating in a…
Author ONA Editor
ONA Editor
The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.
Rediscovering denosumab: From osteoporosis treatment towards a possible role against breast cancer
Science and society collaboration is essential for scientific progress, especially in the health and biomedical…
Immune checkpoint inhibitors significantly increase myocarditis risk in NSCLC patients
A new editorial was published in Volume 12 of Oncoscience on May 2, 2025, titled “Immune checkpoint inhibitors…
Team creates light-activated therapy to target hard-to-treat cancer
University of Texas at Dallas bioengineers, in collaboration with UT Southwestern Medical Centre researchers, are…
Oleanolic acid restores drug sensitivity in sorafenib-resistant hepatocellular carcinoma
Hepatocellular carcinoma (HCC) remains challenging to treat in advanced stages, primarily due to the development…
Scientific breakthrough: We can now halve the price of costly cancer drug
Taxol is one of the most commonly prescribed chemotherapy drugs for breast, ovarian, cervical and…
Daratumumab may help cancer patients with low physical function to live longer, study finds
How cancer patients relying on daratumab feel physically before starting the therapy can predict how long…
Reimagining cancer therapy by targeting the MYC axis
A new review in Genes and Diseases explores the central role of MYC, a master regulatory protein, in…
Novel blood-based biomarker analysis provides insights to improve therapy decisions and treatment outcomes for patients with metastatic disease
New research has identified specific blood-based biomarkers that can predict the failure of prostate cancer…
Paediatric investigation study identifies immune drivers of medulloblastoma metastasis using explainable AI
Medulloblastoma, the most common malignant paediatric brain tumour, presents substantial clinical challenges due to its…